Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and affects 3.8 million Canadians.1–3 Although inhaled medication is the cornerstone of therapy, ...
Both products deliver dry powder asthma medication through Teva’s RespiClick inhaler. The AirDuo RespiClick contains the same active ingredients as GlaxoSmithKline’s inhaler drug Advair, while the ...
(RTTNews) - Teva Canada, a unit of Teva Pharmaceutical Industries Ltd. (TEVA), announced Monday the product availability of Aermony RespiClick, a new device for the treatment of bronchial asthma. The ...
The FINANCIAL — Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) on April 1 announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) inhalation ...
Press releases are posted on Independent.com as a free community service. PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, Inc., a U.S ...
Aermony RespiClick™ (fluticasone propionate inhalation powder), available in three dose options Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and ...
PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced today the launch of a new patient access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results